Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells-Reference-Cited by-同舟云学术

Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells

Published:2015-10-09 Issue:36 Volume:6 Page:38934-38951
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhao Qiaoli¹,Assimopoulou Andreana N.²,Klauck Sabine M.³,Damianakos Harilaos⁴,Chinou Ioanna⁴,Kretschmer Nadine⁵,Rios José-Luis⁶,Papageorgiou Vassilios P.²,Bauer Rudolf⁵,Efferth Thomas¹

Affiliation:

1. Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany

2. Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece

3. Working Group Cancer Genome Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), National Center for Tumor Diseases (NCT), Heidelberg, Germany

4. Faculty of Pharmacy, University of Athens, Athens, Greece

5. Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria

6. Department de Farmacologia, Facultat de Farmàcia, Universitat de València, Valencia, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shikonin, a natural naphthoquinone phytochemical, exerts anti-leukemia effects in human CBF-AML cell lines and zebrafish xenograft models;Biomedicine & Pharmacotherapy;2024-10

2. Pharmacological Significance of Boraginaceae with Special Insights into Shikonin and Its Potential in the Food Industry;Foods;2024-04-27

3. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties;European Journal of Medicinal Chemistry;2024-03

4. Calothrixin B derivatives induce apoptosis and cell cycle arrest on HEL cells through the ERK/Ras/Raf/MEK pathway;Biomedicine & Pharmacotherapy;2024-02

5. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products;Aging and disease;2024